Some studies have shown gut microbial signatures such as increased Bifidobacterium or Lactobacillaceae in PD patients treated with COMT inhibitors (Scheperjans et al., 2015; Hill-Burns et al., 2017; Aho et al., 2019). Here, COMT is linked to Parkinson disease.